Literature DB >> 10209960

Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation.

R H Xing1, S A Rabbani.   

Abstract

Carcinoma of the breast is a leading hormone-dependent malignancy, resulting in a high rate of morbidity and mortality. During the complex multi-step process of tumor promotion, this common cancer is initiated as hormone-responsive (HR), non-metastatic cancer, followed by a gradual transition into a highly metastatic hormone-insensitive (HI) variety which lacks the functional estrogen receptor. This transition of cancer cells causes them to become refractory to hormonal treatment. Urokinase (uPA), a member of the serine protease family has been implicated in the progression of several malignancies including breast cancer. In the current study, we have examined the correlation between hormone sensitivity and uPA expression in HR normal mammary epithelial cells (HMEC) and in MCF-7 and T-47D breast cancer cell lines. Comparison was made with HI breast cancer cells MDA-231. uPA mRNA expression was seen only in the highly invasive, HI breast cancer cells MDA-231. Lack of uPA expression in HR normal (HMEC) and in minimally invasive, HR cells (MCF-7 and T-47D) was due to transcriptional suppression of uPA gene expression as determined by nuclear run-off assays. Since alteration of the DNA methylation status of CpG island in the 5' sequence of oncogenes and tumor suppressor genes has been demonstrated to change their expression, we examined DNA methylation as a potential molecular mechanism for regulating uPA gene transcription in these cancer cells. Southern blot analysis using methylation sensitive enzymes revealed that CpG island of uPA gene are methylated in HR, HMEC, MCF-7 and T-47D cells, whereas they are hypomethylated in HI and MDA-231 cells. Treatment of HR MCF-7 cells with cytosine DNA methyltransferase inhibitor 5' azacytidine caused a dose-dependent induction of uPA mRNA due to demethylation of the CpG island of the uPA gene which led to increased invasive ability of these HR cancer cells. Our results demonstrate that DNA methylation can regulate the transcription of the uPA gene to alter the invasive behaviour of these HR breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209960     DOI: 10.1002/(sici)1097-0215(19990505)81:3<443::aid-ijc19>3.0.co;2-t

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors:  Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2008-10-15       Impact factor: 2.860

2.  ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation.

Authors:  M Seddighzadeh; J N Zhou; U Kronenwett; M C Shoshan; G Auer; M Sten-Linder; B Wiman; S Linder
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

3.  Masked Chimeric Antigen Receptor for Tumor-Specific Activation.

Authors:  Xiaolu Han; Paul D Bryson; Yifan Zhao; Gunce E Cinay; Si Li; Yunfei Guo; Natnaree Siriwon; Pin Wang
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

4.  Urokinase expression in course of benign and malignant mammary lesions: comparison between nodular and healthy tissues.

Authors:  Francesca Ceccarelli; Andrea Fuso; Liana Civitelli; Ersilia Ranieri; Giuliana Caprio; Paola Pagni; Mario Rengo; Sigfrido Scarpa
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-14       Impact factor: 4.553

Review 5.  Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.

Authors:  Niaz Mahmood; Shafaat A Rabbani
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK).

Authors:  Nancy Dos Santos; Golareh Habibi; Michelle Wang; Jennifer H Law; Heather N Andrews; Daniel Wei; Timothy Triche; Shoukat Dedhar; Sandra E Dunn
Journal:  Transl Oncogenomics       Date:  2007-07-23

7.  Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer.

Authors:  Gabriel Moquet-Torcy; Claire Tolza; Marc Piechaczyk; Isabelle Jariel-Encontre
Journal:  Nucleic Acids Res       Date:  2014-09-08       Impact factor: 16.971

Review 8.  Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.

Authors:  Niaz Mahmood; Catalin Mihalcioiu; Shafaat A Rabbani
Journal:  Front Oncol       Date:  2018-02-12       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.